Latest News about MRK
Recent news which mentions MRK
Merck's COVID-19 Pill works Against Omicron, Lab Studies Show
January 28, 2022
Tickers
MRK
From Benzinga
World hits milestone of 10 billion COVID vaccine doses administered, but less than 10% of people in low-income countries have had a first jab
January 28, 2022
From MarketWatch
From Benzinga
From MarketWatch
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster
January 27, 2022
From MarketWatch
Jiangsu Recbio Shoots To Become Hong Kong's First HPV Vaccine Stock
January 27, 2022
From Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
From Benzinga
Vaccinex Posts Two Complete Responses In Pepinemab Combo Trial In Head & Neck Cancer
January 26, 2022
From Benzinga
From Motley Fool
2 Stocks to Buy No Matter What Happens in 2022
January 26, 2022
From Motley Fool
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
From MarketWatch
eFFECTOR Secures $50M Funding From Lincoln Park Capital
January 25, 2022
From Benzinga
These 4 Dow Stocks Are Screaming Buys in 2022
January 25, 2022
From Motley Fool
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
From Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
From Benzinga
Britain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized Patients
January 24, 2022
Tickers
MRK
From Benzinga
3 No-Brainer Healthcare Stocks to Buy Right Now for Less than $150
January 24, 2022
From Motley Fool
Benzinga Bulls And Bears Of The Past Week: ViacomCBS, Ford, Meta, Netflix, Microsoft, Tesla And More
January 22, 2022
From Benzinga
From Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
From MarketWatch
We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone
January 20, 2022
From MarketWatch
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.